American Journal of Cardiology
Volume 106, Issue 1 , Pages 51-55 , 1 July 2010

Linguistic Analysis of In-Office Dialogue Among Cardiologists, Primary Care Physicians, and Patients With Mixed Dyslipidemia

  • Alan S. Brown, MD

      Affiliations

    • Midwest Heart Specialists, Naperville, Illinois
    • ,
  • Lynn Cofer-Chase, MSN, RN, CLS

      Affiliations

    • Midwest Heart Specialists, Naperville, Illinois
    • ,
  • Corey A. Eagan, MPH (Cand)

      Affiliations

    • MBS/Vox, Parsippany, New Jersey
    • Corresponding Author InformationCorresponding author: Tel: (973) 352-2067; fax: (973) 352-2567

Received 2 December 2009 ,Revised 7 February 2010 ,Accepted 7 February 2010.

References 

  1. Hobbs FD, Erhardt LR, Rycroft C Heart Study Investigators. The From the Heart study: a global survey of patient understanding of cholesterol management and cardiovascular risk, and physician–patient communication. Curr Med Res Opin. 2008;24:1267–1278
  2. van Steenkiste B, van der Weijden T, Timmermans D, Vaes J, Stoffers J, Grol R. Patients' ideas, fears and expectations of their coronary risk: barriers for primary prevention. Patient Educ Couns. 2004;55:301–307
  3. Whiteside C, Robbins JA. Cholesterol knowledge and practices among patients compared with physician management in a university primary care setting. Prev Med. 1989;18:526–531
  4. Kapur NK, Ashen D, Blumenthal RS. High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease. Vasc Health Risk Manag. 2008;4:39–57
  5. Capuzzi DM, Guyton JR, Morgan JM, Goldberg AC, Kreisberg RA, Brusco OA, et al. Efficacy and safety of an extended-release niacin (Niaspan): a long-term study. Am J Cardiol. 1998;82:74U–81U85U, 86U
  6. Goldberg AC. Clinical trial experience with extended-release niacin (Niaspan): dose-escalation study. Am J Cardiol. 1998;82:35U–41U
  7. Morgan JM, Capuzzi DM, Guyton JR. A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients. Am J Cardiol. 1998;82:29U–34U39U–41U
  8. Davidson MH. Niacin use and cutaneous flushing: mechanisms and strategies for prevention. Am J Cardiol. 2008;101:14B–19B
  9. Ainsworth-Vaughn N. The discourse of medical encounters. In:  Schiffrin D,  Tannen D,  Hamilton HE editor. The Handbook of Discourse Analysis. Malden, MA: Blackwell; 2001;p. 453–469
  10. Heritage J. Conversation analysis and institutional talk: analyzing data. In:  Silverman D editors. Qualitative Research: Theory, Method and Practice. London: Sage; 1997;p. 161–182
  11. Johnstone B. Qualitative Methods in Sociolinguistics, vol 123. New York: Oxford University Press; 2000;
  12. Aranguri C, Davidson B, Ramirez R. Patterns of communication through interpreters: a detailed sociolinguistic analysis. J Gen Intern Med. 2006;21:623–629
  13. Davidson B, Blum D, Cella D, Hamilton H, Nail L, Waltzman R. Communicating about chemotherapy-induced anemia. J Support Oncol. 2007;5:36–4046
  14. Hamilton HE, Nelson M, Martin P, Cotler SJ. Provider-patient in-office discussions of response to hepatitis C antiviral therapy and impact on patient comprehension. Clin Gastroenterol Hepatol. 2006;4:507–513
  15. Gumperz JJ. On interactional sociolinguistic method. In:  Sarangi S,  Roberts C editor. Talk, Work and Institutional Order Discourse in Medical, Mediation and Management Settings. Berlin: Mouton De Gruyter; 1999;p. 453–471
  16. Hamilton HE. Symptoms and signs in particular: the influence of the medical concern no the shape of physician–patient talk. Commun Med. 2004;1:59–70
  17. Blaha MJ, Blumenthal RS, Brinton EA, Jacobson TA National Lipid Association Taskforce on Non-HDL Cholesterol. The importance of non-HDL cholesterol reporting in lipid management. J Clin Lipidol. 2008;2:267–273
  18. Knapp P, Raynor DK, Berry DC. Comparison of two methods of presenting risk information to patients about the side effects of medicines. Qual Saf Health Care. 2004;13:176–180
  19. Durack-Bown I, Giral P, d'Ivernois JF, Bazin C, Chadarevian R, Benkritly A, et al. Patients' and physicians' perceptions and experience of hypercholesterolaemia: a qualitative study. Br J Gen Pract. 2003;53:851–857
  20. Hahn SR, Lipton RB, Sheftell FD, Cady RK, Eagan CA, Simons SE, et al. Healthcare provider-patient communication and migraine assessment: results of the American Migraine Communication study, phase II. Curr Med Res Opin. 2008;24:1711–1718
  21. Pringle M, Stewart-Evans C. Does awareness of being video-recorded affect doctors' consultation behavior?. Br J Gen Pract. 1990;40:455–458
  22. Speer S, Hutchby I. From ethics to analytics: aspects of participants' orientations to the presence and relevance of recording devices. Sociology. 2003;37:315–337
  23. Labov W. Sociolinguistic Patterns. In: Philadelphia, PA: University of Pennsylvania Press; 1972;p. 61

 This study was supported by funding from Abbott Laboratories, Abbott Park, Illinois.

PII: S0002-9149(10)00608-9

doi: 10.1016/j.amjcard.2010.02.014

American Journal of Cardiology
Volume 106, Issue 1 , Pages 51-55 , 1 July 2010

Article Tools

* Image Usage & Resolution